Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Djibouti Health Journal.
Press releases published on January 23, 2026
January 23, 2026
Calgary Health Foundation commits $1 million to expand bariatric care with Assisted Living Alberta
Indeterminate
GlobeNewswire
January 23, 2026
AIM ImmunoTech Announces Key Dates and Terms Related to Announced Rights Offering
Indeterminate
GlobeNewswire
January 23, 2026
NUTRAHARMONY Recognized as Best Organic Lymphatic Drainage Drops in 2026 by SupplementInsight
Indeterminate
GlobeNewswire
January 23, 2026
Countdown for a Cure Partners with Dr. Taz Bhatia M.D. and hol+ to Advance Mitochondrial Research and Awareness
Indeterminate
GlobeNewswire
January 23, 2026
Environmental Mass Spectrometry Market to Reach USD 1.47 Billion by 2031 | MarketsandMarkets™
Indeterminate
GlobeNewswire
January 23, 2026
20 Million Patients Benefit from da Vinci Surgery Globally
Indeterminate
GlobeNewswire
January 23, 2026
BioCryst Completes Acquisition of Astria Therapeutics, Expanding Leadership in Hereditary Angioedema
Indeterminate
GlobeNewswire
January 23, 2026
Global Polymeric Biomaterials Market to Reach USD 16.93 Billion by 2030 | MarketsandMarkets™
Indeterminate
GlobeNewswire
January 23, 2026
Global Protein Expression Market Poised for 10.9% CAGR Expansion by 2030
Indeterminate
GlobeNewswire
January 23, 2026
Lexicon Pharmaceuticals to Ring the Nasdaq Closing Bell on January 27, 2026 to Celebrate 30th Anniversary
Indeterminate
GlobeNewswire
January 23, 2026
Enovis to Host Fourth Quarter and Full Year 2025 Results Conference Call on February 26th
Indeterminate
GlobeNewswire
January 23, 2026
Adagene Provides Business Update and 2026 Objectives
Indeterminate
GlobeNewswire
January 23, 2026
Daxor Corporation Announces $9 Million Registered Direct Offering
Indeterminate
GlobeNewswire
January 23, 2026
Enlivex Therapeutics Shares to Trade Exclusively on Nasdaq
Indeterminate
GlobeNewswire
January 23, 2026
Ocugen, Inc. Announces Closing of $22.5 Million Underwritten Registered Direct Offering of Common Stock
Indeterminate
GlobeNewswire
January 23, 2026
Alveus Therapeutics Announces FDA Clearance of IND and First Patient Dosed in Phase 1b Trial of ALV-100 for Obesity
Indeterminate
GlobeNewswire
January 23, 2026
AMN Healthcare to Hold Fourth Quarter and Full Year 2025 Earnings Conference Call on Thursday, February 19, 2026
Indeterminate
GlobeNewswire